Thermo Fisher Scientific Inc
TMO463.040USD
-4.640-0.99%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
174.79BMarket Cap
26.83P/E TTM
More Details of Thermo Fisher Scientific Inc Company
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, the Company provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, the Company provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Company’s Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
Company Info
Ticker SymbolTMO
Company nameThermo Fisher Scientific Inc
IPO dateAug 27, 1980
Founded at1960
CEOMr. Marc N. Casper
Number of employees125000
Security typeOrdinary Share
Fiscal year-endAug 27
Address168 Third Avenue
CityWALTHAM
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code02451
Phone17816221000
Websitehttps://www.thermofisher.com/
Ticker SymbolTMO
IPO dateAug 27, 1980
Founded at1960
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
113.96K
-33.93%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
38.30K
+26.12%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
19.57K
-8.34%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
13.80K
+28.80%
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
13.71K
-19.50%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
12.69K
-3.06%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.62K
+7.01%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
113.96K
-33.93%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
38.30K
+26.12%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
19.57K
-8.34%
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
13.80K
+28.80%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Service
4.38B
42.30%
Consumables
4.35B
42.01%
Instruments
1.63B
15.69%
By RegionUSD
Name
Revenue
Proportion
North America
5.51B
53.19%
Europe
2.62B
25.32%
Asia Pacific
1.89B
18.25%
Other Regions
337.00M
3.25%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Service
4.38B
42.30%
Consumables
4.35B
42.01%
Instruments
1.63B
15.69%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.82%
BlackRock Institutional Trust Company, N.A.
4.58%
State Street Global Advisors (US)
4.38%
Capital World Investors
2.93%
T. Rowe Price Associates, Inc.
2.32%
Other
76.97%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
8.82%
BlackRock Institutional Trust Company, N.A.
4.58%
State Street Global Advisors (US)
4.38%
Capital World Investors
2.93%
T. Rowe Price Associates, Inc.
2.32%
Other
76.97%
Shareholder Types
Shareholders
Proportion
Investment Advisor
51.50%
Investment Advisor/Hedge Fund
28.50%
Bank and Trust
2.99%
Research Firm
2.77%
Pension Fund
2.48%
Sovereign Wealth Fund
2.05%
Hedge Fund
1.74%
Family Office
0.23%
Family Office
0.20%
Other
7.54%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
4319
349.38M
92.55%
-7.58M
2025Q1
4395
350.27M
92.78%
-5.82M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
2023Q1
3992
353.61M
91.65%
-5.21M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
33.31M
8.82%
+229.59K
+0.69%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
17.28M
4.58%
+75.83K
+0.44%
Mar 31, 2025
State Street Global Advisors (US)
16.54M
4.38%
+91.46K
+0.56%
Mar 31, 2025
Capital World Investors
11.06M
2.93%
+1.63M
+17.30%
Mar 31, 2025
T. Rowe Price Associates, Inc.
8.74M
2.32%
-1.59M
-15.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
8.13M
2.15%
+269.80K
+3.43%
Mar 31, 2025
Capital Research Global Investors
7.61M
2.02%
-307.93K
-3.89%
Mar 31, 2025
JP Morgan Asset Management
6.49M
1.72%
+829.84K
+14.65%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
6.05M
1.6%
+483.36K
+8.68%
Dec 31, 2024
Morgan Stanley Smith Barney LLC
4.48M
1.19%
+26.92K
+0.61%
Mar 31, 2025
View more
Related ETFs
Updated: 5 hours ago
Updated: 5 hours ago
Name
Proportion
Amplify Weight Loss Drug & Treatment ETF
3.98%
Honeytree US Equity ETF
3.74%
Monarch Blue Chips Core ETF
3.24%
Proshares Ultra Health Care
3.13%
Health Care Select Sector SPDR Fund
3.13%
Goldman Sachs Future Health Care Equity ETF
3.07%
iShares U.S. Healthcare ETF
3.02%
Parnassus Value Select ETF
2.97%
AdvisorShares Focused Equity ETF
2.92%
Fidelity MSCI Health Care Index ETF
2.7%
View more
Amplify Weight Loss Drug & Treatment ETF
Proportion3.98%
Honeytree US Equity ETF
Proportion3.74%
Monarch Blue Chips Core ETF
Proportion3.24%
Proshares Ultra Health Care
Proportion3.13%
Health Care Select Sector SPDR Fund
Proportion3.13%
Goldman Sachs Future Health Care Equity ETF
Proportion3.07%
iShares U.S. Healthcare ETF
Proportion3.02%
Parnassus Value Select ETF
Proportion2.97%
AdvisorShares Focused Equity ETF
Proportion2.92%
Fidelity MSCI Health Care Index ETF
Proportion2.7%
Dividend
A total of
2.29B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Feb 22, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Apr 14, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 14, 2023
Mar 14, 2023
Nov 10, 2022
TMO.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 16, 2023 going ex on Dec 14, 2022
Dec 15, 2022
Jan 16, 2023
Dec 14, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
